by Guest Contributer | May 21, 2021 | Drug Legislation, Feature, Marijuana & CBD
By guest contributors Bill Judge, JD, LL.M., and Nick Hartman of the Drug Screening Compliance Institute State and local marijuana laws around the country are fast-changing and often confusing. In this article NDASA members Bill Judge and Nick Hartman take on recent...
by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, Marijuana & CBD, Resources
“Medical Review Officers will not verify a drug test as negative based upon information that a physician recommended that the employee use “medical marijuana.” Please note that marijuana remains a drug listed in Schedule I of the Controlled Substances Act. It remains...
by NDASA | Apr 23, 2021 | For Employers and Workplace Safety & Wellness Professionals, Marijuana & CBD, Resources
Marijuana is an impairing substance. The user experiences reduced motor coordination, short-term memory loss and altered reaction time, all of which has destructive effects in the workplace. High doses of THC, the active ingredient in the cannabis plant, can cause...
by NDASA | Nov 3, 2020 | Drug & Alcohol Testing, Feature, Marijuana & CBD
By Chuck Marting, Colorado Mobile Testing , Impairment Detection Academy, Host of Clearing the Haze podcast. At the beginning of this third quarter I met with one of our clients who had been selected for a random DOT drug test. As we sat down, the driver who also...
